Shots:
- Schrödinger has entered into a strategic agreement with BMS to deploy Bunsen, its agentic AI co-scientist, across BMS’s research organization, expanding the companies’ long-standing partnership
- As per the deal, Schrödinger will work with BMS to develop new Bunsen capabilities alongside its computational technologies for large-scale chemical exploration & RetroSynth, its AI-driven synthesis planning platform
- The collaboration enables BMS to accelerate molecule discovery & research decisions using Schrödinger’s computational platform, with Bunsen designed to plan, execute, and interpret complex molecular discovery workflows
Ref: Businesswire | Image: Schrödinger & BMS | Press Release
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
